SWOT Analysis for Jubilant Pharmova Ltd.

Add SWOT widget to your site/app

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Companies with reducing Debt
Increasing Revenue every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Companies with reducing Debt

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
Increasing Trend in Non-Core Income

Companies with growing costs YoY for long term projects

Increasing Trend in Non-Core Income

Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Sells by Superstar Investors

Sells by Superstar Investors

High Piotroski Score - Companies with strong financials
Stocks with improving cash flow, with good durability
Bullish or Bearish Candlestick Strength - Indices
Bullish Engulfing Pattern (Bullish Reversal)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

High Piotroski Score - Companies with strong financials

Stocks with improving cash flow, with good durability

Bullish or Bearish Candlestick Strength - Indices

Bullish Engulfing Pattern (Bullish Reversal)

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Jubilant Pharmova Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Jubilant Pharmova Ltd. has 30 Strengths, 2 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential